Cyclo Therapeutics’ Trappsol Cyclo was able to induce clinical improvement in seven out of eight children with Neimann-Pick ...

GeneDx has a big market in mind for its genetic testing: every newborn baby. The 24-year-old-company wants to make the ...

GeneDx CEO Katherine Stueland likes the potential of newborn testing, but she says her Stamford, Connecticut, company is ...

Accumulation of clots causes some of the most severe symptoms of sickle cell disease, including strokes, kidney failure, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...